J&J
25 Sep 2021
A booster dose of the Johnson & Johnson COVID jab increases its efficacy rate to 94%, the drugmaker said. The company is expected to state its case to US regulators. Follow DW for the latest.
17 Mar 2021
WHO advisers say Johnson and Johnson's COVID-19 jab seems to work against worrying coronavirus variants. The vaccine has been approved by the EU, US, Canada and South Africa.
14 Feb 2021
Alex Gorsky said mutations of the virus may force people to get inoculated every year. Meanwhile, Eli Lilly's combination antibody therapy has been granted emergency use authorization in the US. Follow DW for the latest.